Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
8.60
-0.93 (-9.76%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Immix Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 456 | 276 | 61 | 137 | 32 | 47 | |
| Market Cap Growth | 950.83% | 355.41% | -55.98% | 331.07% | -32.18% | - | |
| Enterprise Value | 357 | 261 | 42 | 118 | 15 | 51 | |
| Last Close Price | 8.60 | 5.23 | 2.20 | 6.92 | 2.29 | 3.56 | |
| PB Ratio | 4.85 | 2.94 | 4.57 | 8.49 | 2.42 | 2.61 | |
| P/TBV Ratio | 4.86 | 2.94 | 4.57 | 8.38 | 2.42 | 2.61 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.08 | - | - | 0.00 | |
| Net Debt / Equity Ratio | -1.06 | -1.06 | -1.25 | -1.08 | -1.02 | -0.98 | |
| Net Debt / EBITDA Ratio | 3.34 | 3.34 | 0.73 | 1.09 | 1.64 | 13.04 | |
| Net Debt / FCF Ratio | 4.03 | 4.03 | 1.05 | 1.53 | 1.81 | 11.07 | |
| Quick Ratio | 9.93 | 9.93 | 2.26 | 5.02 | 10.75 | 87.46 | |
| Current Ratio | 10.01 | 10.01 | 2.33 | 5.32 | 11.70 | 90.01 | |
| Return on Equity (ROE) | -55.00% | -55.00% | -147.33% | -106.22% | -52.84% | -367.80% | |
| Return on Assets (ROA) | -29.30% | -29.30% | -66.11% | -57.92% | -31.04% | -9.02% | |
| Return on Capital Employed (ROCE) | -31.60% | -31.60% | -159.00% | -99.60% | -60.30% | -7.50% | |
| Earnings Yield | -6.46% | -10.68% | -35.72% | -11.22% | -25.80% | -51.85% | |
| FCF Yield | -5.41% | -8.95% | -26.06% | -8.31% | -23.23% | -3.38% | |
| Buyback Yield / Dilution | -16.55% | -16.55% | -63.11% | -24.87% | -278.13% | -8.82% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.